Company intelligence / Profile preview

Nanopharmacia

Puebla, Puebla, Mexico

Ownership: Private
Development stage: Other

Overview

Nanopharmacia operates as a leading precision oncology laboratory in Mexico and Latin America, offering genetic and genomic testing for cancer diagnosis and treatment planning. The company has over 10 years of research in nanotechnology with clinical experience and has been granted 24 patents for its products.[1][2] Their innovations improve bioavailability and safety profiles of therapies for cancer, diabetes, and infectious diseases.[2]

Therapeutic areas: OncologyEndocrinologyInfectious Diseases
Modalities: NanoparticleDiagnostic testing
Industry: Biotech

Partnerships

Invitae

Beyond the preview

Go deeper on Nanopharmacia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanopharmacia.

Explore the full profile